We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSI icon
351
iShares MSCI KLD 400 Social ETF
DSI
$5.13B
$342K 0.01%
6,954
– –
ESRX
352
DELISTED
Express Scripts Holding Company
ESRX
$337K ﹤0.01%
4,516
-22,825
-83% -$1.46M
VRTX icon
353
Vertex Pharmaceuticals
VRTX
$122B
$327K ﹤0.01%
2,183
– –
SMFG icon
354
Sumitomo Mitsui Financial
SMFG
$166B
$325K ﹤0.01%
+37,385
New +$303K
MCHP icon
355
Microchip Technology
MCHP
$41.7B
$308K ﹤0.01%
7,000
– –
BBVA icon
356
Banco Bilbao Vizcaya Argentaria
BBVA
$146B
$307K ﹤0.01%
+36,125
New +$308K
SJM icon
357
J.M. Smucker
SJM
$12.9B
$304K ﹤0.01%
2,445
– –
BSX icon
358
Boston Scientific
BSX
$68.7B
$298K ﹤0.01%
12,002
– –
BAX icon
359
Baxter International
BAX
$12B
$297K ﹤0.01%
4,590
– –
CAJ
360
DELISTED
Canon, Inc.
CAJ
$296K ﹤0.01%
+7,925
New +$296K
TWX
361
DELISTED
Time Warner Inc
TWX
$288K ﹤0.01%
3,150
+700
+29% +$66.1K
CMG icon
362
Chipotle Mexican Grill
CMG
$42.6B
$286K ﹤0.01%
49,400
-2,500
-5% -$14.9K
WPP icon
363
WPP
WPP
$4.25B
$276K ﹤0.01%
+3,045
New +$270K
ZTS icon
364
Zoetis
ZTS
$32.4B
$274K ﹤0.01%
3,800
– –
ADI icon
365
Analog Devices
ADI
$178B
$264K ﹤0.01%
2,964
– –
A icon
366
Agilent Technologies
A
$39B
$255K ﹤0.01%
3,812
– –
RCL icon
367
Royal Caribbean
RCL
$78B
$255K ﹤0.01%
2,140
-85
-4% -$10.5K
PDCO
368
DELISTED
Patterson Companies, Inc.
PDCO
$249K ﹤0.01%
6,899
– –
BNY
369
Bank of New York Mellon
BNY
$107B
$247K ﹤0.01%
4,587
– –
GS icon
370
Goldman Sachs
GS
$306B
$233K ﹤0.01%
914
-55
-6% -$13.5K
HIG icon
371
Hartford Financial Services
HIG
$38.4B
$232K ﹤0.01%
4,129
– –
TRV icon
372
Travelers Companies
TRV
$81.3B
$232K ﹤0.01%
1,710
+50
+3% +$6.6K
SWK icon
373
Stanley Black & Decker
SWK
$14.4B
$231K ﹤0.01%
1,360
– –
CAT icon
374
Caterpillar
CAT
$393B
$219K ﹤0.01%
+1,392
New +$193K
WHR icon
375
Whirlpool
WHR
$2.47B
$217K ﹤0.01%
1,286
-500
-28% -$84.7K
12 13 14
15
16

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.